Cita APA

Shirakura, T., Nomura, J., Matsui, C., Kobayashi, T., Tamura, M., & Masuzaki, H. (2016). Febuxostat, a novel xanthine oxidoreductase inhibitor, improves hypertension and endothelial dysfunction in spontaneously hypertensive rats. Naunyn Schmiedebergs Arch Pharmacol.

Citación estilo Chicago

Shirakura, Takashi, Johji Nomura, Chieko Matsui, Tsunefumi Kobayashi, Mizuho Tamura, y Hiroaki Masuzaki. "Febuxostat, a Novel Xanthine Oxidoreductase Inhibitor, Improves Hypertension and Endothelial Dysfunction in Spontaneously Hypertensive Rats." Naunyn Schmiedebergs Arch Pharmacol 2016.

Cita MLA

Shirakura, Takashi, et al. "Febuxostat, a Novel Xanthine Oxidoreductase Inhibitor, Improves Hypertension and Endothelial Dysfunction in Spontaneously Hypertensive Rats." Naunyn Schmiedebergs Arch Pharmacol 2016.